When we determined the percentage of CD206- and Arg1-positive M2 macrophages in tumor tissue, we found that administration of macrophages treated with T47D-miR-138-5p exosomes increased the percentage of M2 cells (Figure 6D-E). This evidence concerns the gene ARG1 and neoplasm.